Biological mechanisms of cancer-related fatigue in breast cancer survivors after treatment: a scoping review

被引:11
|
作者
Garcia-Gonzalez, David [1 ]
Medino-Munoz, Juan [2 ]
Romero-Elias, Maria [3 ]
Garcia-Foncillas, Jesus [1 ,4 ,5 ]
Ruiz-Casado, Ana [3 ,6 ]
机构
[1] Univ Autonoma Madrid UAM, Sch Med, Madrid 28029, Spain
[2] Hosp Univ Fuenlabrada, Lib, Madrid 28942, Spain
[3] IDIPHISA, Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid 28222, Spain
[4] IIS Fdn Jimenez Diaz, Oncohealth Inst, Translat Oncol Div, Madrid 28040, Spain
[5] UAM, Hosp Univ Fdn Jimenez Diaz, Dept Med Oncol, Madrid 28040, Spain
[6] Hosp Univ Puerta Hierro Majadahonda, IDIPHISA, Dept Med Oncol, Madrid 28222, Spain
关键词
Cancer-related fatigue; Biomarkers; Inflammation; Hypothalamo-hypophyseal system; Autonomic nervous system; Diet; METHYLTRANSFERASE GENOTYPE VAL158MET; INFLAMMATORY BIOMARKERS; PERSISTENT FATIGUE; GENE POLYMORPHISMS; RISK-FACTORS; CORTISOL; DISEASE; CHEMOTHERAPY; ASSOCIATION; VARIABILITY;
D O I
10.1007/s11764-023-01477-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeCancer-related fatigue (CRF) is the most common symptom experienced by cancer survivors. It is a multidimensional symptom affecting physical, emotional, and/or cognitive spheres, different from other types of fatigue. Characteristically is not alleviated by sleep or rest. CRF could have specific features in breast cancer survivors (BCS), because of sex, hormones, and distinct treatments. On the other hand, more than 25% of BCS report persistent CRF for 10 years or more after the diagnosis. The present study aims to recapitulate the knowledge about the biological mechanisms that potentially drive CRF in BCS after treatment.MethodsTo answer a broad question, a scoping review methodology was used. Data were collated from three bibliographic databases: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). Studies were selected if they had included more than 20 BCS, after finishing their treatment, fatigue was measured with a quantitative scale and biomarkers were analyzed.ResultsThe final database was composed of 1896 records. Sixty-four studies finally met the eligibility criteria. Inflammation (61%), hypothalamic-pituitary-adrenal (HPA) axis dysregulation (14%), autonomic nervous system (ANS) dysfunction (11%), and diet (9%) were the biological pathways most frequently studied. Unfortunately, results from studies about inflammation and HPA axis show many inconsistencies.ConclusionMore research about the role of ANS dysfunction and diet on the pathogenesis of CRF would be warranted according to the results of the review. There are some fields such as endocannabinoid systems, mitochondrial dysfunction, gut microbiota, and oxidative stress that have been insufficiently explored.Implications for Cancer SurvivorsTo widen the scope of future research in the physiopathology of CRF, it is necessary to identify mechanisms that would be potentially involved and have been insufficiently explored. Because of the high prevalence of CRF in BCS and the tremendous impact that fatigue has in their quality of life, it is essential to improve the efficacy of the treatments through a good knowledge of the biological basis of CRF.
引用
收藏
页码:414 / 444
页数:31
相关论文
共 50 条
  • [21] Low heart rate variability and cancer-related fatigue in breast cancer survivors
    Crosswell, Alexandra D.
    Lockwood, Kimberly G.
    Ganz, Patricia A.
    Bower, Julienne E.
    PSYCHONEUROENDOCRINOLOGY, 2014, 45 : 58 - 66
  • [22] Relationship of cancer-related fatigue with psychoneurophysiological (PNP) symptoms in breast cancer survivors
    Hsiao, Chao-Pin
    Von Ah, Diane
    Chen, Mei-Kuang
    Saligan, Leorey N.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2024, 68
  • [23] Cancer-related fatigue in breast cancer survivors: more evidence for a physiological substrate
    Ramos, J.
    Cantos, B.
    Maximiano, C.
    Cebolla, H.
    Fiuza-Luces, C.
    Gutierrez, L.
    Osorio, P.
    Cerrato, J.
    Sanchez, J. L.
    Nunez, B.
    Garate, A.
    Pagola, I.
    Alejo, L. B.
    Lucia, A.
    Ruiz-Casado, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Evaluation of Screening Instruments for Cancer-Related Fatigue Syndrome in Breast Cancer Survivors
    Alexander, Susanna
    Minton, Ollie
    Stone, Patrick C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1197 - 1201
  • [25] Gut microbiome alterations in breast cancer survivors with cancer-related fatigue.
    Chan, Alexandre
    Shwe, Maung
    Koh, Samantha An Qi
    Zhu, Congju
    Chan, Yi Shan
    Tan, Si Hui
    Ang, Xiao Jun
    Lee, Wei Quan
    Khine, Wei Wei Thwe
    Lee, Yuan Kun
    Lau, Quek Choon
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] PREVALENCE, PREDICTORS, AND TRAJECTORY OF CANCER-RELATED FATIGUE IN BREAST CANCER (BC) SURVIVORS
    Andrykowski, Michael A.
    Jacobsen, Paul
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 50 - 50
  • [27] Mechanisms of cancer-related fatigue
    Ryan, Julie L.
    Carroll, Jennifer K.
    Ryan, Elizabeth P.
    Mustian, Karen M.
    Fiscella, Kevin
    Morrow, Gary R.
    ONCOLOGIST, 2007, 12 : 22 - 34
  • [28] The definitions, assessment, and dimensions of cancer-related fatigue: A scoping review
    Keane, Kayla F.
    Wickstrom, Jordan
    Livinski, Alicia A.
    Blumhorst, Catherine
    Wang, Tzu-fang
    Saligan, Leorey N.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [29] Effects of dyadic-based physical activity intervention on cancer-related fatigue among cancer survivors: A scoping review
    Song, Dongyu
    Liu, Yuzhou
    Lai, Claudia K. Y.
    Li, Yuli
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [30] Contributors to cancer-related fatigue in childhood cancer survivors and the use of non-pharmacological interventions: a scoping review protocol
    Levesque, Ariane
    Caru, Maxime
    Duval, Michel
    Laverdiere, Caroline
    Sultan, Serge
    JBI EVIDENCE SYNTHESIS, 2021, 19 (09) : 2423 - 2433